ACE2 and viral infectious disease: In another study, SARS-CoV-2 pseudovirus was shown to infect ACE2 deficient T cells in a dose-dependent manner, and this infection was specifically inhibited by a humanized anti-CD147 antibody (Meplazumab), suggesting that overexpression of CD147 promotes viral infection (40).